Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study

Background. This study aims to determine whether the administration of ferric carboxymaltose (FCM) in patients with acute heart failure (AHF) and iron deficiency (ID) improves morbidity and mortality. Methods. We studied 890 consecutive patients admitted for AHF. Patients were divided into six group...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Vilella, Raquel, Donoso Trenado, Víctor, Jover Pastor, Pablo, Sánchez-Lázaro, Ignacio, Martínez Dolz, Luis, Almenar Bonet, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699465/
https://www.ncbi.nlm.nih.gov/pubmed/36362983
http://dx.doi.org/10.3390/life12111828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699465/
https://www.ncbi.nlm.nih.gov/pubmed/36362983
http://dx.doi.org/10.3390/life12111828

Ejemplares similares